O, S., M, P., SK, S., R, R., S, P., SK, D. M., . . . R, D. (2020). DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG. Apoptosis : an international journal on programmed cell death, 25(3-4), 233. https://doi.org/10.1007/s10495-020-01591-8
Chicago Style (17th ed.) CitationO, Shriwas, Priyadarshini M, Samal SK, Rath R, Panda S, Das Majumdar SK, Muduly DK, Botlagunta M, and Dash R. "DDX3 Modulates Cisplatin Resistance in OSCC Through ALKBH5-mediated M6A-demethylation of FOXM1 and NANOG." Apoptosis : An International Journal on Programmed Cell Death 25, no. 3-4 (2020): 233. https://doi.org/10.1007/s10495-020-01591-8.
MLA (9th ed.) CitationO, Shriwas, et al. "DDX3 Modulates Cisplatin Resistance in OSCC Through ALKBH5-mediated M6A-demethylation of FOXM1 and NANOG." Apoptosis : An International Journal on Programmed Cell Death, vol. 25, no. 3-4, 2020, p. 233, https://doi.org/10.1007/s10495-020-01591-8.